Angela G Arnold
Overview
Explore the profile of Angela G Arnold including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
659
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Muraresku C, McCormick E, Rockart L, Crowley T, Asher S, Back A, et al.
Genes (Basel)
. 2024 Jul;
15(7).
PMID: 39062646
Purpose: Genetic counselors (GCs) increasingly play key roles in advancing genomic medicine through innovative research. Here, we examine one large cohort of GCs' evolving contributions to the literature, with the...
2.
Gordhandas S, Rios-Doria E, Cadoo K, Catchings A, Maio A, Kemel Y, et al.
J Natl Cancer Inst
. 2023 Feb;
115(5):560-569.
PMID: 36744932
Background: We sought to determine the prevalence of germline pathogenic variants (gPVs) in unselected patients with endometrial cancer (EC), define biallelic gPVs within tumors, and describe their associations with clinicopathologic...
3.
Navitski A, Al-Rawi D, Makker V, Weigelt B, Zamarin D, Liu Y, et al.
JCO Precis Oncol
. 2022 Oct;
6:e2200349.
PMID: 36265117
No abstract available.
4.
Liu Y, Maio A, Kemel Y, Salo-Mullen E, Sheehan M, Tejada P, et al.
Cancer
. 2022 Aug;
128(21):3870-3879.
PMID: 36041233
Background: Germline risk assessment is increasing as part of cancer care; however, disparities in subsequent genetic counseling are unknown. Methods: Pan-cancer patients were prospectively consented to tumor-normal sequencing via custom...
5.
Fiala E, Jayakumaran G, Mauguen A, Kennedy J, Bouvier N, Kemel Y, et al.
Nat Cancer
. 2021 Jul;
2:357-365.
PMID: 34308366
The spectrum of germline predisposition in pediatric cancer continues to be realized. Here we report 751 solid tumor patients who underwent prospective matched tumor-normal DNA sequencing and downstream clinical use...
6.
Salo-Mullen E, Maio A, Mukherjee S, Bandlamudi C, Shia J, Kemel Y, et al.
JCO Precis Oncol
. 2021 Jul;
5.
PMID: 34250384
Materials And Methods: Patients with pan-cancer (n = 11,081) underwent matched tumor-normal sequencing with consent for germline analysis. Medical records and tumors were reviewed and analyzed. Prevalence of PVs was...
7.
Yelskaya Z, Arnold A, Marcell V, Tang L, Salo-Mullen E, Strong V, et al.
Eur J Hum Genet
. 2021 Apr;
29(7):1164.
PMID: 33907319
No abstract available.
8.
Cowan R, Nobre S, Pradhan N, Yasukawa M, Zhou Q, Iasonos A, et al.
Gynecol Oncol
. 2021 Mar;
161(2):521-526.
PMID: 33712278
Objective: Prior data suggested that women with incidentally detected occult invasive ovarian cancer (OIOC) at the time of risk-reducing salpingo-oophorectomy (RRSO) for BRCA mutation may have poorer prognoses than would...
9.
Yelskaya Z, Arnold A, Marcell V, Tang L, Salo-Mullen E, Strong V, et al.
Eur J Hum Genet
. 2021 Feb;
29(7):1103-1109.
PMID: 33619332
Hereditary Diffuse Gastric Cancer (HDGC) syndrome is associated with CDH1 germline likely pathogenic/pathogenic variants. Carriers of CDH1 germline likely pathogenic/pathogenic variants are predisposed to diffuse gastric cancer and lobular breast...
10.
Yang C, Arnold A, Catchings A, Rai V, Stadler Z, Zhang L
Breast Cancer Res Treat
. 2021 Jan;
185(3):869-877.
PMID: 33452952
Purpose: Mutations in RAD51D are associated with a predisposition to primary ovarian, fallopian tube, and peritoneal carcinoma. Our study aims to characterize a RAD51D missense variant in a hereditary ovarian...